BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36192709)

  • 1. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.
    Liang J; Dai W; Li Z; Liang X; Xiao M; Xie C; Li X
    BMC Cancer; 2022 Oct; 22(1):1033. PubMed ID: 36192709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
    Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
    World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of tumor vascular normalization in colorectal cancer mouse mode induced by recombinant human endostatin by intravoxel incoherent motion diffusion-weighted magnetic resonance imaging].
    Zhu SB; Huang JL; Pan JH; Ding H; Zhao XX; Zhang D; Shi CZ; Pan YL
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):421-428. PubMed ID: 31216827
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment.
    Liang J; Li Z; Li J; Peng C; Dai W; He H; Zeng S; Xie C
    Front Oncol; 2020; 10():1376. PubMed ID: 32974136
    [No Abstract]   [Full Text] [Related]  

  • 5. Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China.
    Deng W; Hu J; Li M; Yang S; Xie Z; Chen J
    Expert Rev Pharmacoecon Outcomes Res; 2022 Oct; 22(7):1117-1126. PubMed ID: 35899310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
    Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
    World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Treatment Efficacy of Antiangiogenic Therapy Combined With Hypoxia-Activated Prodrugs Online Using Functional MRI.
    Ma M; Liang J; Zhang D; Xu X; Cheng Q; Xiao Z; Shi C; Luo L
    Front Oncol; 2021; 11():672047. PubMed ID: 33996599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI.
    Liang J; Cheng Q; Huang J; Ma M; Zhang D; Lei X; Xiao Z; Zhang D; Shi C; Luo L
    Angiogenesis; 2019 Aug; 22(3):457-470. PubMed ID: 31147887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
    Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
    J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
    Xu B; Zhang Q; Sun T; Li W; Teng Y; Hu X; Bondarenko I; Adamchuk H; Zhang L; Trukhin D; Wang S; Zheng H; Tong Z; Shparyk Y; Wang Q;
    BioDrugs; 2021 May; 35(3):337-350. PubMed ID: 33826080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performing IVIM-DWI using the multifunctional nanosystem for the evaluation of the antitumor microcirculation changes.
    Gao P; Liu Y; Shi C; Liu Y; Luo L
    MAGMA; 2020 Aug; 33(4):517-526. PubMed ID: 31897903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring Bevacizumab-Induced Tumor Vascular Normalization by Intravoxel Incoherent Motion Diffusion-Weighted MRI.
    Li B; Xu D; Zhou J; Wang SC; Cai YX; Li H; Xu HB
    J Magn Reson Imaging; 2022 Aug; 56(2):427-439. PubMed ID: 34873766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
    Liang J; Ma R; Chen H; Zhang D; Ye W; Shi C; Luo L
    AJR Am J Roentgenol; 2019 Apr; 212(4):717-726. PubMed ID: 30699010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the Process of Endostar-Induced Tumor Vascular Normalization by Non-contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI.
    Pan JH; Zhu S; Huang J; Liang J; Zhang D; Zhao X; Ding H; Qin L; Shi C; Luo L; Pan Y
    Front Oncol; 2018; 8():524. PubMed ID: 30483478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers.
    Ji C; Zhang Q; Guan W; Guo T; Chen L; Liu S; He J; Zhou Z
    Oncotarget; 2017 Jul; 8(30):49293-49302. PubMed ID: 28514733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative study of preoperative staging of gastric cancer using intravoxel incoherent motion diffusion-weighted imaging as a potential clinical index.
    Zeng Q; Hong Y; Cheng J; Cai W; Zhuo H; Hou J; Wang L; Lu Y; Cai J
    Eur J Radiol; 2021 Aug; 141():109627. PubMed ID: 34126429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter real-world study comparing the clinical equivalence of trastuzumab biosimilar HLX02 and reference trastuzumab in the treatment of HER-2-positive breast cancer.
    Deng W; Hu J; Yang S; Xie Z; Li M; Li J; Zhuang W; Chen J
    Am J Cancer Res; 2023; 13(7):3113-3122. PubMed ID: 37559995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Intravoxel Incoherent Motion Diffusion-Weighted Imaging in Predicting and Monitoring Early Efficacy of Anti-Angiogenic Therapy in the C6 Glioma Rat Model.
    Hou W; Xue Y; Qian Y; Pan H; Xu M; Shen Y; Li X; Yu Y
    Front Oncol; 2021; 11():842169. PubMed ID: 35155219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer.
    Hu X; Ma Z; Xu B; Li S; Yao Z; Liang B; Wang J; Liao W; Lin L; Wang C; Zheng S; Wu Q; Huang Q; Yu L; Wang F; Shi M
    Cancer Commun (Lond); 2023 Aug; 43(8):909-937. PubMed ID: 37434399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective Analysis.
    Park JH; Yeo JH; Kim YS; Park I; Ahn HK; Cho EK; Shin DB; Yang JY; Kim HS; Lee WK; Sym SJ
    Am J Clin Oncol; 2022 Feb; 45(2):61-65. PubMed ID: 34991106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.